We will be developing an EEG-based biomarker for the effects of ketamine infusion in patients with Depression. We will be analyzing the effects of ketamine infusion on Depression symptoms and EEG signals.
Phase:
PHASE1
Details
Lead Sponsor:
Soterix Medical
Collaborator:
Columbia University Irving Medical Center, New York, NY